Perspective Therapeutics, Inc.
CATX
$2.99
-$0.13-4.17%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.79M | -26.19M | -37.49M | -25.97M | -21.49M |
| Total Depreciation and Amortization | 1.14M | 1.13M | 1.00M | 775.00K | 733.00K |
| Total Amortization of Deferred Charges | -- | -- | 7.00K | -- | -- |
| Total Other Non-Cash Items | 2.42M | 2.14M | 11.14M | 1.61M | 1.71M |
| Change in Net Operating Assets | 2.57M | -8.55M | 687.00K | 7.29M | -913.00K |
| Cash from Operations | -20.65M | -31.47M | -24.66M | -16.29M | -19.95M |
| Capital Expenditure | -14.20M | -6.86M | -5.08M | -1.99M | -1.03M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.21M | -102.70M | 33.61M | 15.98M | 5.29M |
| Cash from Investing | 15.02M | -109.55M | 28.54M | 13.99M | 4.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.00K | -15.00K | -13.00K | -13.00K | -13.00K |
| Issuance of Common Stock | 160.00K | 164.38M | 0.00 | 226.00K | 145.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 147.00K | 164.36M | -13.00K | 213.00K | 132.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.48M | 23.34M | 3.87M | -2.09M | -15.56M |